3
Announcements
Trials
Browse
Landscape
Status
Unknown
1
Recruiting
1
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Observational
1
Sponsor
Cancer Type
Thoracic
1
Sarcoma
1
Plasma cell
1
Other solid neoplasm
1
Other hematologic neoplasm
1
NET
1
Myeloid
1
Lymphoid
1
Head & Neck
1
Gynecologic
1
Genitourinary
1
Gastrointestinal
1
Endocrine
1
Dermatologic
1
CNS
1
Breast
1
Conditions
Neoplasms
4
Prostatic Neoplasms
2
Multiple Myeloma
2
Melanoma
2
Kidney Neoplasms
2
Head and Neck Neoplasms
2
Breast Neoplasms
2
Waldenstrom Macroglobulinemia
1
Vulvar Neoplasms
1
Vaginal Neoplasms
1
Uterine Neoplasms
1
Uterine Cervical Neoplasms
1
Urinary Bladder Neoplasms
1
Ureteral Neoplasms
1
Tongue Neoplasms
1
Thyroid Neoplasms
1
Thymus Neoplasms
1
Testicular Neoplasms
1
Substance-Related Disorders
1
Stomach Neoplasms
1
Skin Neoplasms
1
Sarcoma, Synovial
1
Sarcoma, Kaposi
1
Sarcoma
1
Salivary Gland Neoplasms
1
Rectal Neoplasms
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Pheochromocytoma
1
Pharyngeal Neoplasms
1
Penile Neoplasms
1
Interventions
Temozolomide
94
Radiotherapy
59
Bevacizumab
59
Radiosurgery
41
Carboplatin
27
Irinotecan
26
Magnetic Resonance Spectroscopy
25
Surgical Procedures, Operative
23
Etoposide
22
Carmustine
20
Filgrastim
18
Erlotinib Hydrochloride
17
Cyclophosphamide
16
Cisplatin
16
Vincristine
15
Lomustine
15
Lapatinib
15
Sorafenib
13
Radiation
13
Trastuzumab
12
Nivolumab
12
Imatinib Mesylate
12
Thalidomide
11
Surveys and Questionnaires
11
Granulocyte Colony-Stimulating Factor
11
Radiotherapy, Intensity-Modulated
10
Aminolevulinic Acid
10
temsirolimus
9
Topotecan
9
Thiotepa
9
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Brain Neoplasms
×
Patient Reported Outcome Measures
×
Clear all
NCT04028479
2024-12-18
ROOT
Taproot Health
Completed
167 enrolled